Litcius/Paper detail

X-ray structure of human aldo–keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis

Maja Marinović, Sofija S. Bekić, Michaël Kugler, J. Brynda, Jana Škerlová, Dušan Škorić, Pavlína Řezáčová, Edward T. Petri, Andjelka S. Ćelić

2022RSC Medicinal Chemistry15 citationsDOIOpen Access PDF

Abstract

in complex with this C-ring fused bile acid tetrazole was determined by X-ray crystallography at 1.4 Å resolution, revealing that the C24 carboxylate is anchored to the catalytic oxyanion site (H117, Y55); meanwhile the tetrazole interacts with a tryptophan (W227) important for steroid recognition. Molecular docking predicts that all four top AKR1C3 inhibitors bind with nearly identical geometry, suggesting that C-ring bile acid fused tetrazoles represent a new class of AKR1C3 inhibitors.

Topics & Concepts

Aldo-keto reductaseTetrazoleReductaseChemistryBile acidDocking (animal)StereochemistryBiochemistryEnzymeMedicineNursingAldose Reductase and TaurineSynthesis and Biological EvaluationCannabis and Cannabinoid Research
X-ray structure of human aldo–keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis | Litcius